Bioventix PLC
Save
–
Market cap
28.11x
Current P/E
29.41x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services.
Similar securities
Based on sector and market capitalization
Report issue